Abstract
Neeser et al. (1) challenge my argument that self-monitoring of blood glucose (SMBG) in type 2 diabetic patients not taking insulin is not beneficial for lowering glycemia and therefore is a waste of (a lot of) money (2). In a meta-analysis of six randomized controlled trials, Welschen et al. (3) found a significant reduction of 0.39% in HbA1c (A1C) levels in type 2 diabetic patients not taking insulin who performed SMBG. Welschen et al. did point out that the reduction was only significant in two of the trials and that the conclusion that SMBG was …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
